BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24247820)

  • 1. Where are we in diabetic nephropathy: microRNAs and biomarkers?
    McClelland A; Hagiwara S; Kantharidis P
    Curr Opin Nephrol Hypertens; 2014 Jan; 23(1):80-6. PubMed ID: 24247820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics.
    Conserva F; Pontrelli P; Accetturo M; Gesualdo L
    J Nephrol; 2013; 26(5):811-20. PubMed ID: 23543479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.
    Alvarez ML; Distefano JK
    Diabetes Res Clin Pract; 2013 Jan; 99(1):1-11. PubMed ID: 23102915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.
    Kato M; Natarajan R
    Ann N Y Acad Sci; 2015 Sep; 1353(1):72-88. PubMed ID: 25877817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of microRNA in diabetic nephropathy: isolation, quantification and biological function.
    Kantharidis P; Hagiwara S; Brennan E; McClelland AD
    Nephrology (Carlton); 2015 Mar; 20(3):132-9. PubMed ID: 25487691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy.
    DiStefano JK; Taila M; Alvarez ML
    Curr Diab Rep; 2013 Aug; 13(4):582-91. PubMed ID: 23666892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy.
    Mafi A; Yadegar N; Salami M; Salami R; Vakili O; Aghadavod E
    Pathol Res Pract; 2021 Nov; 227():153618. PubMed ID: 34649056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNAs in Diabetic Kidney Disease.
    Chung AC
    Adv Exp Med Biol; 2015; 888():253-69. PubMed ID: 26663187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs: potential therapeutic targets in diabetic complications of the cardiovascular and renal systems.
    Figueira MF; Monnerat-Cahli G; Medei E; Carvalho AB; Morales MM; Lamas ME; da Fonseca RN; Souza-Menezes J
    Acta Physiol (Oxf); 2014 Jul; 211(3):491-500. PubMed ID: 24837225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of MicroRNA in the Pathogenesis of Diabetic Nephropathy.
    Szostak J; Gorący A; Durys D; Dec P; Modrzejewski A; Pawlik A
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
    Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
    Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
    Kelly DJ; Buck D; Cox AJ; Zhang Y; Gilbert RE
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: The role of microRNAs in kidney disease.
    Li JY; Yong TY; Michael MZ; Gleadle JM
    Nephrology (Carlton); 2010 Sep; 15(6):599-608. PubMed ID: 20883280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy].
    Wittmann I; Degrell P; Komáromy A; Molnár GA; Wagner Z; Wagner L; Mazák I; Nagy J
    Orv Hetil; 2003 Mar; 144(13):613-9. PubMed ID: 12728786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
    Dewanjee S; Bhattacharjee N
    Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of candidate genes' polymorphism in the development of diabetic nephropathy].
    Grzeszczak W; Zukowska-Szczechowska E
    Wiad Lek; 1998; 51 Suppl 2():11-23. PubMed ID: 9686528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs and the kidney: coming of age.
    Saal S; Harvey SJ
    Curr Opin Nephrol Hypertens; 2009 Jul; 18(4):317-23. PubMed ID: 19424061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of microRNAs in kidney homeostasis and disease.
    Chandrasekaran K; Karolina DS; Sepramaniam S; Armugam A; Wintour EM; Bertram JF; Jeyaseelan K
    Kidney Int; 2012 Apr; 81(7):617-27. PubMed ID: 22237749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
    Elmarakby AA; Sullivan JC
    Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression.
    Mafi A; Aghadavod E; Mirhosseini N; Mobini M; Asemi Z
    J Cell Physiol; 2018 Jan; 234(1):42-50. PubMed ID: 30078212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.